An open-label study to evaluate the safety profile of the new 500mg film-coated tablet formulation of boosted saquinavir (Invirase 500mg) in HIV-1 infected patients.
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Ritonavir; Saquinavir
- Indications HIV-1 infections
- Focus Adverse reactions
- Acronyms ESPrES-500
- Sponsors Roche
- 16 Feb 2008 Status changed from in progress to completed.
- 09 Jun 2006 New trial record.